AC
FLACU

Aaron Cowen’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Aaron Cowen’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-87,500
Closed -$908K – 134
2020
Q4 		$908K Buy
+87,500
New +$913K 0.01% 98

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Aaron Cowen's FLACU Position: Q1 2021 in Review

Aaron Cowen sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q1 2021, closing a stake of 87,500 shares — an estimated $908K sold.

Aaron Cowen first reported a position in FLACU in Q4 2020 and held it in 1 quarter. The position peaked at $908K in Q4 2020. 37 funds tracked by Wall St. Rank hold FLACU as of Q1 2021.

  • Aaron Cowen reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • Aaron Cowen sold 87,500 Frazier Lifesciences Acquisition Corporation Unit shares in Q1 2021, an estimated $908K.
  • Aaron Cowen first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • Aaron Cowen's Frazier Lifesciences Acquisition Corporation Unit position peaked at $908K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q1 2021.

Based on Suvretta Capital Management's 13F filing for Q1 2021, filed 17 May 2021.